Boston Scientific Corporation
Boston Scientific Corporation（BSX）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · BSX · 截至 2026年6月8日
活动摘要
买入笔数
4
P-Purchase only
卖出笔数
18
近12个月
买卖比
0.22
Buy/Sell (by trades)
整体情绪
Boston Scientific Corporation内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
BSX 季度内部人买卖趋势
BSX 内幕交易卖出 · BSX 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · BSX CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
BSX 高管卖出股份 · BSX 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| May 28, 2026 | Mahoney Michael F Chairman, President & CEO · Director | Gift | 386,755 | — | Form 4 |
| May 20, 2026 | Pegus Cheryl Director | Purchase | 1,770 | $100K | Form 4 |
| May 20, 2026 | LUDWIG EDWARD J Director | Purchase | 3,580 | $203K | Form 4 |
| May 20, 2026 | Habiger David C Director | Purchase | 2,250 | $126K | Form 4 |
| May 19, 2026 | Habiger David C Director | Purchase | 2,200 | $125K | Form 4 |
| May 7, 2026 | Zane Ellen M Director | Award | 3,800 | — | Form 4 |
| May 7, 2026 | WICHMANN DAVID S Director | Award | 3,800 | — | Form 4 |
| May 7, 2026 | Weber Christophe Pierre Director | Award | 1,140 | — | Form 4 |
| May 7, 2026 | Weber Christophe Pierre Director | Award | 1,767 | — | Form 4 |
| May 7, 2026 | Morano Susan E Director | Award | 1,281 | — | Form 4 |
| May 7, 2026 | Morano Susan E Director | Award | 3,800 | — | Form 4 |
| May 7, 2026 | Mega Jessica L Director | Award | 3,800 | — | Form 4 |
| May 7, 2026 | LUDWIG EDWARD J Director | Award | 3,800 | — | Form 4 |
| May 7, 2026 | Habiger David C Director | Award | 3,800 | — | Form 4 |
| May 2, 2026 | O'Connor Padraig Andrew EVP, Global Operations | Option | 1,802 | — | Form 4 |
| May 2, 2026 | O'Connor Padraig Andrew EVP, Global Operations | Other | 872 | $49K | Form 4 |
| May 2, 2026 | Butcher Arthur C EVP& Grp Pres, MedSurg & APAC | Option | 2,102 | — | Form 4 |
| May 2, 2026 | Butcher Arthur C EVP& Grp Pres, MedSurg & APAC | Other | 1,007 | $57K | Form 4 |
| Mar 2, 2026 | Morano Susan E Director | Award | 24 | — | Form 4 |
| Mar 2, 2026 | Weber Christophe Pierre Director | Award | 323 | — | Form 4 |
| Mar 2, 2026 | Weber Christophe Pierre Director | Award | 556 | — | Form 4 |
| Mar 1, 2026 | Woodworth Emily SVP, Global Controller and CAO | Option | 838 | — | Form 4 |
| Mar 1, 2026 | Woodworth Emily SVP, Global Controller and CAO | Other | 372 | $29K | Form 4 |
| Feb 19, 2026 | Butcher Arthur C EVP& Grp Pres, MedSurg & APAC | Other | 6,851 | $519K | Form 4 |
| Feb 16, 2026 | O'Connor Padraig Andrew EVP, Global Operations | Option | 905 | — | Form 4 |
Mahoney Michael F
Chairman, President & CEO · Director
日期
May 28
股数
386,755
均价
—
总金额
—
Butcher Arthur C
EVP& Grp Pres, MedSurg & APAC
日期
May 2
股数
1,007
均价
$56.50
总金额
$57K
Butcher Arthur C
EVP& Grp Pres, MedSurg & APAC
日期
Feb 19
股数
6,851
均价
$75.76
总金额
$519K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 BSX 内幕交易
BSX 内幕交易
Boston Scientific Corporation（BSX）内幕交易数据来源于公司内部人（包括Mahoney Michael F (Chairman, President & CEO · Director), O'Connor Padraig Andrew (EVP, Global Operations), Butcher Arthur C (EVP& Grp Pres, MedSurg & APAC)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。BSX内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Boston Scientific Corporation机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
BSX 内幕交易 · 5个问题Boston Scientific Corporation（BSX）的内部人包括高管和董事，如Mahoney Michael F (Chairman, President & CEO · Director), O'Connor Padraig Andrew (EVP, Global Operations), Butcher Arthur C (EVP& Grp Pres, MedSurg & APAC)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026